Ancora Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$505K Buy
8,052
+1,421
+21% +$114K 0.01% 525
2025
Q4
$632K Buy
6,631
+659
+11% +$64.6K 0.01% 490
2025
Q3
$583K Buy
5,972
+2,350
+65% +$243K 0.01% 526
2025
Q2
$389K Hold
3,622
0.01% 583
2025
Q1
$365K Buy
3,622
+450
+14% +$45.3K 0.01% 585
2024
Q4
$283K Sell
3,172
-84
-3% -$7.39K 0.01% 636
2024
Q3
$273K Buy
3,256
+10
+0.3% +$788 0.01% 628
2024
Q2
$250K Hold
3,246
0.01% 618
2024
Q1
$222K Sell
3,246
-119
-4% -$7.65K 0.01% 656
2023
Q4
$195K Buy
3,365
+2,608
+345% +$139K ﹤0.01% 673
2023
Q3
$40K Hold
757
﹤0.01% 970
2023
Q2
$41K Buy
757
+157
+26% +$8.2K ﹤0.01% 956
2023
Q1
$30K Sell
600
-18
-3% -$848 ﹤0.01% 1029
2022
Q4
$29K Buy
618
+18
+3% +$779 ﹤0.01% 1086
2022
Q3
$23K Hold
600
﹤0.01% 1295
2022
Q2
$22K Sell
600
-409
-41% -$16.6K ﹤0.01% 1406
2022
Q1
$45K Buy
1,009
+600
+147% +$26K ﹤0.01% 1303
2021
Q4
$17K Hold
409
﹤0.01% 1634
2021
Q3
$18K Buy
+409
New +$18.1K ﹤0.01% 1505
2018
Q4
Sell
-220
Closed -$8K 685
2018
Q3
$8K Buy
+220
New +$7.68K ﹤0.01% 1213

Other funds holding BSX

Ancora Advisors's BSX Position: Q1 2026 in Review

Ancora Advisors increased its Boston Scientific (BSX) stake by 21% in Q1 2026, buying an estimated $114K and bringing the position to 8,052 shares worth $505K. The position accounts for 0.01% of the portfolio, ranked #525.

Ancora Advisors first reported a position in BSX in Q3 2018 and has held it in 20 quarters since. The position peaked at $632K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Ancora Advisors held 8,052 shares of Boston Scientific worth $505K as of Q1 2026.
  • Ancora Advisors bought 1,421 Boston Scientific shares in Q1 2026, an estimated $114K.
  • Boston Scientific made up 0.01% of Ancora Advisors's portfolio in Q1 2026, its #525 holding.
  • Ancora Advisors first reported a position in Boston Scientific in Q3 2018 and has held it in 20 quarters since.
  • Ancora Advisors's Boston Scientific position peaked at $632K in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.